stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Frei - Play StoreApp Store
InstallierenInstallieren
logo
Tango Therapeutics IncTNGX
$23.608.46%1.84

Tango Therapeutics Inc (TNGX)

Date: 2026-11-03 16:00O: 22.09H: 23.91L: 21.99C: 23.60Vol: 989.5k
Schlusskurs vom Vortag:
$21.76
Offen:
$22.09
24-Stunden-Volumen:
995,099
Relatives Volumen:
0.18
Marktkapitalisierung:
$3.98B
Einnahmen:
$56.99M
Nettoeinkommen (Verlust:
-$107.23M
KGV:
-
EPS:
-$0.8199
Netto-Cashflow:
-$142.55M
1W Leistung:
+3.10%
1M Leistung:
+1.55%
6M Leistung:
+12.49%
1Y Leistung:
+194.63%
1-Tages-Spanne:
$21.99$23.91
1-Wochen-Bereich:
$21.71$23.71
52-Wochen-Spanne:
$7.37$34.39

Tango Therapeutics Inc Aktie (TNGX) Unternehmensprofil

Firmenname
Tango Therapeutics Inc
Telefon
(857) 320-4900
Adresse
201 BROOKLINE AVENUE, BOSTON, USA
Mitarbeiter
137
X
-
Nächster Verdiensttermin
2026-11-03
Neueste SEC-Einreichungen
SEC
TNGX-Diskussionen auf X
X

 

Marktkapitalisierung

 

Umsatz

 

Nettogewinn

 

Free Cashflow

 

ENV

 

Tango Therapeutics Inc Aktie (TNGX) Hochstufungen & Herabstufungen

DatumAktionAnalytikerRatingänderung
2026-10-16EingeleitetWilliam BlairOutperform
2026-07-15EingeleitetJP MorganOverweight
2026-06-26HochstufungJefferiesHold → Buy
2026-06-08HochstufungWolfe ResearchPeer Perform → Outperform

Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)

ZeitraumTrendFY 2025FY 2024FY 2023FY 2022FY 2021
Enddatum des Zeitraums2025-12-312024-12-312022-12-312022-12-312021-12-31
Revenue USD (M)62.3836.5336.5324.8637.04
Research and development USD (M)132.17115.20115.20105.9177.64
Operating expenses USD (M)173.67150.70150.70135.9395.23
Operating income USD (M)-111.29-114.17-114.17-111.07-58.19
Income before tax USD (M)-101.59-101.61-101.61-108.12-57.94
Income tax expense USD (M)0.000.130.130.050.29
Net income USD (M)-101.59-101.74-101.74-108.18-58.24
Basic EPS USD/shares-0.87-1.08-1.08-1.23-
Diluted EPS USD/shares-0.87-1.08-1.08-1.23-
Basic weighted shares shares (M)116.1794.5794.5787.82-
Diluted weighted shares shares (M)116.1794.5794.5787.82-

Tango Therapeutics Inc-Aktie (TNGX) Insiderhandel

  • ADAM CRYSTALNov 02 '26
    Officer
    Transaktion
    Proposed Sale
    Kosten
    $22.72
    #Aktien
    20,000
    Wert ($)
    454,400
    #Aktien Gesamt
    0
  • Crystal AdamOct 01 '26
    President, R&D
    Transaktion
    Option Exercise
    Kosten
    $5.20
    #Aktien
    27,000
    Wert ($)
    140,400
    #Aktien Gesamt
    142,743
  • Crystal AdamOct 01 '26
    President, R&D
    Transaktion
    Sale
    Kosten
    $24.47
    #Aktien
    27,000
    Wert ($)
    660,796
    #Aktien Gesamt
    115,743
  • Jessica NewcombSep 22 '26
    Officer
    Transaktion
    Proposed Sale
    Kosten
    $22.33
    #Aktien
    15,231
    Wert ($)
    340,108
    #Aktien Gesamt
    0
  • Newcomb JessicaSep 22 '26
    Principal Accounting Officer
    Transaktion
    Sale
    Kosten
    $24.22
    #Aktien
    8,200
    Wert ($)
    198,613
    #Aktien Gesamt
    59,121
  • Crystal AdamSep 01 '26
    President, R&D
    Transaktion
    Sale
    Kosten
    $22.37
    #Aktien
    27,000
    Wert ($)
    603,909
    #Aktien Gesamt
    115,743
  • Crystal AdamSep 01 '26
    President, R&D
    Transaktion
    Option Exercise
    Kosten
    $5.20
    #Aktien
    27,000
    Wert ($)
    140,400
    #Aktien Gesamt
    142,743
  • Crystal AdamAug 03 '26
    President, R&D
    Transaktion
    Sale
    Kosten
    $27.24
    #Aktien
    27,000
    Wert ($)
    735,517
    #Aktien Gesamt
    115,743
  • ADAM CRYSTALAug 03 '26
    Officer
    Transaktion
    Proposed Sale
    Kosten
    $27.18
    #Aktien
    81,000
    Wert ($)
    2,201,580
    #Aktien Gesamt
    0
  • Crystal AdamAug 03 '26
    President, R&D
    Transaktion
    Option Exercise
    Kosten
    $5.20
    #Aktien
    27,000
    Wert ($)
    140,400
    #Aktien Gesamt
    142,743
InsiderhandelBeziehungDatumTransaktionKosten#AktienWert ($)#Aktien Gesamt
ADAM CRYSTALOfficerNov 02 '26Proposed Sale$22.7220,000454,4000
Crystal AdamPresident, R&DOct 01 '26Option Exercise$5.2027,000140,400142,743
Crystal AdamPresident, R&DOct 01 '26Sale$24.4727,000660,796115,743
Jessica NewcombOfficerSep 22 '26Proposed Sale$22.3315,231340,1080
Newcomb JessicaPrincipal Accounting OfficerSep 22 '26Sale$24.228,200198,61359,121
Crystal AdamPresident, R&DSep 01 '26Sale$22.3727,000603,909115,743
Crystal AdamPresident, R&DSep 01 '26Option Exercise$5.2027,000140,400142,743
Crystal AdamPresident, R&DAug 03 '26Sale$27.2427,000735,517115,743
ADAM CRYSTALOfficerAug 03 '26Proposed Sale$27.1881,0002,201,5800
Crystal AdamPresident, R&DAug 03 '26Option Exercise$5.2027,000140,400142,743

Tango Therapeutics Inc Aktie (TNGX) Neueste Nachrichten

Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 25, 2026
Oct 25, 2026
Oct 24, 2026
Oct 24, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 20, 2026
Oct 20, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 11, 2026
Oct 11, 2026
Oct 11, 2026
Oct 11, 2026
Oct 11, 2026
Oct 11, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 10, 2026
Sep 10, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 04, 2026
Sep 04, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026

Ähnlich wie TNGX